Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Reg Reform Panel To Review FDA Example Of “Best Practices”

Executive Summary

The HHS Advisory Committee on Regulatory Reform will hear a presentation from the Center for Drug Evaluation & Research as an example of "best practices" during its inaugural meeting

You may also be interested in...



HHS Reg Reform Committee To Discuss Adverse Event Reporting June 10

HHS' advisory committee on regulatory reform will discuss adverse event reporting during its June 10-11 meeting in Minneapolis, Minn

HHS Reg Reform Committee To Discuss Adverse Event Reporting June 10

HHS' advisory committee on regulatory reform will discuss adverse event reporting during its June 10-11 meeting in Minneapolis, Minn

CBER Lot Release Requirement Should Be Eliminated – PhRMA

The lot release requirement for biologics should be eliminated, the Pharmaceutical Research & Manufacturers of America maintained in comments submitted to the HHS Advisory Committee on Regulatory Reform

Related Content

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel